116 related articles for article (PubMed ID: 22846648)
1. Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): in vitro maturation (IVM) is not indicated in the new GnRH antagonist era.
de Ziegler D; Streuli I; Gayet V; Frydman N; Bajouh O; Chapron C
Fertil Steril; 2012 Aug; 98(2):290-3. PubMed ID: 22846648
[TBL] [Abstract][Full Text] [Related]
2. Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm.
Guzman L; Ortega-Hrepich C; Albuz FK; Verheyen G; Devroey P; Smitz J; De Vos M
Fertil Steril; 2012 Aug; 98(2):503-7.e1-2. PubMed ID: 22365339
[TBL] [Abstract][Full Text] [Related]
3. In vitro maturation of oocytes: uncommon indications.
Grynberg M; El Hachem H; de Bantel A; Benard J; le Parco S; Fanchin R
Fertil Steril; 2013 Apr; 99(5):1182-8. PubMed ID: 23380185
[TBL] [Abstract][Full Text] [Related]
4. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.
Gremeau AS; Andreadis N; Fatum M; Craig J; Turner K; McVeigh E; Child T
Fertil Steril; 2012 Aug; 98(2):355-60. PubMed ID: 22658347
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
6. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
7. [In vitro maturation--a potential approach of infertility treatment of patients with PCOS].
Kostov I; Ingilizova G
Akush Ginekol (Sofiia); 2013; 52(4):25-8. PubMed ID: 24283075
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
[TBL] [Abstract][Full Text] [Related]
9. In vitro maturation of immature oocytes and IVF/ICSI in PCOS patients.
Cha KY; Lee DR; Cho JH; Yoon TK
J Indian Med Assoc; 2006 Aug; 104(8):446, 448, 473. PubMed ID: 17240801
[TBL] [Abstract][Full Text] [Related]
10. In-vitro maturation of immature oocytes for infertile women with PCOS.
Chian RC
Reprod Biomed Online; 2004 May; 8(5):547-52. PubMed ID: 15151718
[TBL] [Abstract][Full Text] [Related]
11. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
[TBL] [Abstract][Full Text] [Related]
12. Follicular fluid and supernatant from cultured cumulus-granulosa cells improve in vitro maturation in patients with polycystic ovarian syndrome.
Madkour A; Bouamoud N; Kaarouch I; Louanjli N; Saadani B; Assou S; Aboulmaouahib S; Sefrioui O; Amzazi S; Copin H; Benkhalifa M
Fertil Steril; 2018 Sep; 110(4):710-719. PubMed ID: 30196968
[TBL] [Abstract][Full Text] [Related]
13. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
14. In vitro maturation of human oocytes.
Lin YH; Hwang JL
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):95-9. PubMed ID: 17197347
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
16. The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.
Kol S; Homburg R; Alsbjerg B; Humaidan P
Acta Obstet Gynecol Scand; 2012 Jun; 91(6):643-7. PubMed ID: 22428986
[TBL] [Abstract][Full Text] [Related]
17. [In vitro maturation and fertilization of oocytes from unstimulated cycles in women with infertility due to polycystic ovary syndrome].
Li Y; Jiang JJ; Ma SY; Li M; Hu JM; Zhao LX; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):388-91. PubMed ID: 16008889
[TBL] [Abstract][Full Text] [Related]
18. [In vitro maturation, fertilization and embryo transfer of human immature oocyte].
Liu JY; Qian Y; Mao YD; Ding W; Yang NM
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):230-2. PubMed ID: 12885372
[TBL] [Abstract][Full Text] [Related]
19. Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments.
Nogueira D; Friedler S; Schachter M; Raziel A; Ron-El R; Smitz J
Fertil Steril; 2006 Mar; 85(3):578-83. PubMed ID: 16500322
[TBL] [Abstract][Full Text] [Related]
20. [In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization].
Ellenbogen A; Atamny R; Fainaru O; Meidan E; Rotfarb N; Michaeli M
Harefuah; 2011 Nov; 150(11):833-6, 876. PubMed ID: 22428202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
